| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2026-01-29 | 876 | $230.92 | $202.29kSell |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2026-01-29 | 991 | $229.94 | $227.87kSell |
| Jonathan Sheena | Director | 2026-01-28 | 191 | $237.66 | $45.39kSell |
| John Fesko | PRESIDENT CHIEF BUS. OFFICER | 2026-01-28 | 928 | $237.66 | $220.55kSell |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2026-01-28 | 1,237 | $237.66 | $293.99kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-01-28 | 1,200 | $237.66 | $285.19kSell |
| Steven Leonard Chapman | CEO AND PRESIDENT | 2026-01-28 | 3,648 | $237.66 | $866.99kSell |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2026-01-28 | 1,176 | $237.44 | $279.23kSell |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2026-01-28 | 1,000 | $237.66 | $237.66kSell |
| Steven Leonard Chapman | CEO AND PRESIDENT | 2026-01-27 | 2,322 | $240.53 | $558.51kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.98% | 12,389,033 | $2.86B | Institution |
| Price T Rowe Associates Inc | 8.66% | 11,947,415 | $2.76B | Institution |
| Jpmorgan Chase Co | 8.43% | 11,628,914 | $2.69B | Institution |
| Blackrock Inc | 7.94% | 10,964,351 | $2.53B | Institution |
| Claremont Creek Ventures L P | 4.25% | 5,864,630 | $1.36B | Insider |
| Roelof Botha | 4.06% | 5,609,069 | $1.30B | Insider |
| Sc XII Management LLC | 3.93% | 5,421,122 | $1.25B | Insider |
| Matthew Rabinowitz | 3.48% | 4,809,420 | $1.11B | Insider |
| James Healy | 3.40% | 4,697,100 | $1.09B | Insider |
| Farallon Capital Management LLC | 3.08% | 4,253,452 | $983.14M | Institution |